Mercer Global Advisors’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$287K Buy
+22,094
New +$251K ﹤0.01% 2858
2026
Q1
Sell
-14,604
Closed -$188K 3220
2025
Q4
$188K Buy
14,604
+4,030
+38% +$49.7K ﹤0.01% 2586
2025
Q3
$118K Buy
+10,574
New +$102K ﹤0.01% 2497

Other funds holding ANGO

Mercer Global Advisors's ANGO Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in AngioDynamics (ANGO) in Q2 2026: 22,094 shares worth $287K. The stake represents ﹤0.01% of the portfolio and ranks #2858 among its holdings. This is a return to the name: Mercer Global Advisors previously reported a position in ANGO as recently as Q4 2025.

Mercer Global Advisors first reported a position in ANGO in Q3 2025 and has held it in 3 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Mercer Global Advisors held 22,094 shares of AngioDynamics worth $287K as of Q2 2026.
  • AngioDynamics was a new Mercer Global Advisors position in Q2 2026.
  • AngioDynamics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2858 holding.
  • Mercer Global Advisors first reported a position in AngioDynamics in Q3 2025 and has held it in 3 quarters since.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.